期刊文献+
共找到94篇文章
< 1 2 5 >
每页显示 20 50 100
Delayed diagnosis of alpha-1-antitrypsin deficiency following post-hepatectomy liver failure: A case report 被引量:3
1
作者 Benjamin Norton Jemimah Denson +3 位作者 Christopher Briggs Matthew Bowles David Stell Somaiah Aroori 《World Journal of Gastroenterology》 SCIE CAS 2016年第11期3289-3295,共7页
Post-hepatectomy liver failure(PHLF) is a leading cause of morbidity and mortality following major liver resection. The development of PHLF is dependent on the volume of the remaining liver tissue and hepatocyte funct... Post-hepatectomy liver failure(PHLF) is a leading cause of morbidity and mortality following major liver resection. The development of PHLF is dependent on the volume of the remaining liver tissue and hepatocyte function. Without effective pre-operative assessment, patients with undiagnosed liver disease could be at increased risk of PHLF. We report a case of a 60-year-old male patient with PHLF secondary to undiagnosed alpha-1-antitrypsin deficiency(AATD) following major liver resection. He initially presented with acute large bowel obstruction secondary to a colorectal adenocarcinoma, which had metastasized to the liver. There was no significant past medical history apart from mild chronic obstructive pulmonary disease. After colonic surgery and liver directed neo-adjuvant chemotherapy, he underwent a laparoscopic partially extended right hepatectomy and radio-frequency ablation. Post-operatively he developed PHLF. The cause of PHLF remained unknown, prompting reanalysis of the histology, which showed evidence of AATD. He subsequently developed progressive liver dysfunction, portal hypertension, and eventually an extensive parastomal bleed, which led to his death; this was ultimately due to a combination of AATD and chemotherapy. This case highlights that formal testing for AATD in all patients with a known history of chronic obstructive pulmonary disease, heavy smoking, or strong family history could help prevent the development of PHLF in patients undergoing major liver resection. 展开更多
关键词 Post-hepatectomy LIVER failure alpha-1-antitrypsin DEFICIENCY HEPATECTOMY Functional LIVER remnant L
下载PDF
Associations of Polymorphism of rs9944155, rs1051052, and rs1243166 Locus Allele in Alpha-1-antitrypsin with Chronic Obstructive Pulmonary Disease in Uygur Population of Kashgar Region 被引量:3
2
作者 Xue-Mei Zhong Li Li +9 位作者 Huai-Zhen Wang Xiao-Guang Zou Ping Zhang Mireban Rexiati Maimaitiaili Tnerxun Jie Ren Mukeremu Yasen Juan Zhang Ai-Fang Zheng Paierda Aini 《Chinese Medical Journal》 SCIE CAS CSCD 2018年第6期684-688,共5页
Background: Previous studies conducted in various geographical and ethnical populations have shown that Alpha-1 -antitrypsin (Alpha-1-AT) expression affects the occurrence and progression of chronic obstructive puh... Background: Previous studies conducted in various geographical and ethnical populations have shown that Alpha-1 -antitrypsin (Alpha-1-AT) expression affects the occurrence and progression of chronic obstructive puh-nonary disease (COPD). We aimed to explore the associations of rs9944155AG, rsl051052AG, and rs1243166AG polymorphisms in the A lpha-1-A T gene with the risk of COPD in Uygur population in the Kashgar region. Methods: From March 2013 to December 2015. a total of 225 Uygur COPD patients and 198 healthy people were recruited as cases and controls, respectively, in Kashgar region. DNA was extracted according to the protocol of the DNA genome kit, and Sequenom MassARRAY single-nucleotide polymorphism technology was used for genotype determination. Serum concentration of Alpha-1-AT was detected by enzyme-linked immunosorbent assay. A logistic regression model was used to estimate the associations of polymorphisms with COPD. Results: The rs1243166-G allele was associated with a higher risk of COPD (odds ratio [OR] = 2.039, 95% confidence interval [CI]: 1.116-3.725, P = 0.019). In cases, Alpha-1-AT levels were the highest among participants can-yiug rs1243166 AG genotype, followed by AA and GG genotype (χ2 = 11.89, P = 0.003). Similarly, the rs1051052-G allele was associated with a higher risk of COPD (OR = 19.433, 95% CI: 8.783-43.00, P 〈 0.001). The highest Alpha-1-ATlevels were observed in cases carrying rs1051052 AA genotype, followed by cases with AG and GG genotypes (χ2= 122.45, P 〈 0.001). However, individuals with rs9944155-G allele exhibited a lower risk of COPD than those carrying the rs9944155-A allele (OR = 0.121, 95% CI: 0.070-0.209, P 〈 0.001 ). in both cases and controls, no significant difference in Alpha-l-AT levels was observed among various rs9944115 genotypes. Conclusions: rs 1243166, rs9944155, and rs 1051052 sites of Alpha- I-A Tmay be associated with the COPD morbidity in Uygur population. While rs 1243166-G allele and rs1051052-G allele are associated with an increased risk of developing COPD, rs9944155-G allele is a protect locus in Uygur population. Alpha1-AT levels in Uygur COPD patients were lower than those in healthy people and differed among patients with different rs 1051052 AG and rs 1243166 AG genotypes. 展开更多
关键词 alpha-1-antitrypsin Chronic Obstructive Pulmonary Disease POLYMORPHISM Uygur Population
原文传递
DISTRIBUTION OF ALPHA-1-ANTITRYPSIN VARIANT ETOKYO AND ITS IMPLICATION IN HUMAN POPULATION GENETICS
3
作者 应启龙 梁植权 《Chinese Science Bulletin》 SCIE EI CAS 1986年第16期1144-1148,共5页
Ⅰ. INTRODUCTION Alpha-1-antitrypsin (A1AT; locus symbol, PI) is one of the main protease inhibitors in serum. Up to now there are at least 50 A1AT variants that have been found in human populations (Cox, D. W., priva... Ⅰ. INTRODUCTION Alpha-1-antitrypsin (A1AT; locus symbol, PI) is one of the main protease inhibitors in serum. Up to now there are at least 50 A1AT variants that have been found in human populations (Cox, D. W., private communication). The distribution of A1AT variants appears highly racial specificity and geographical variability. This 展开更多
关键词 DISTRIBUTION OF alpha-1-antitrypsin VARIANT ETOKYO AND ITS IMPLICATION IN HUMAN POPULATION GENETICS
原文传递
α1-抗胰蛋白酶对未成熟脑白质损伤小鼠运动功能的影响
4
作者 李文冬 宋娟 +4 位作者 张含 杨禄祥 岳宇阳 张新玲 王永 《中国当代儿科杂志》 CAS CSCD 北大核心 2024年第2期181-187,共7页
目的探讨α1-抗胰蛋白酶(α1-antitrypsin,AAT)对未成熟脑白质损伤小鼠成年期运动功能的影响。方法将5日龄C57BL/6J幼鼠随机分为假手术组(n=27)、缺氧缺血(hypoxia-ischemia,HI)+生理盐水组(n=27)、HI+AAT组(n=27)。通过HI法建立未成熟... 目的探讨α1-抗胰蛋白酶(α1-antitrypsin,AAT)对未成熟脑白质损伤小鼠成年期运动功能的影响。方法将5日龄C57BL/6J幼鼠随机分为假手术组(n=27)、缺氧缺血(hypoxia-ischemia,HI)+生理盐水组(n=27)、HI+AAT组(n=27)。通过HI法建立未成熟脑白质损伤小鼠模型。HI+AAT组分别于HI前24 h、HI后立即及HI后72 h腹腔注射AAT(50 mg/kg);HI+生理盐水组在相同时间腹腔注射相同剂量生理盐水。造模后7 d和55 d进行头颅磁共振T2加权成像扫描。2月龄时利用Catwalk步态分析系统评估成年期小鼠的静态、动态和协调性参数。结果与假手术组小鼠相比,HI损伤小鼠造模后7 d头颅磁共振T2加权像呈现高信号,可见脑白质明显损伤;造模后55 d脑白质损伤仍存在。与假手术组小鼠相比,HI+生理盐水组小鼠爪印面积、最大接触面积、平均压强、最大压强、爪印宽度、平均速度、身体速度、步幅长度、摆动速度、步态模式AA占比、爪印耦合(左后爪→左前爪)占比降低(P<0.05);HI+生理盐水组爪间距离、步态模式AB占比、位相滞后(左前爪→左后爪)占比升高(P<0.05)。与HI+生理盐水组小鼠相比,HI+AAT组小鼠平均速度、身体速度、步幅长度、摆动速度(右前爪)升高(P<0.05)。结论未成熟脑白质损伤小鼠在成年期可表现出明显运动功能障碍,而应用AAT可改善其部分运动功能。 展开更多
关键词 缺氧缺血 脑白质损伤 Α1-抗胰蛋白酶 Catwalk步态分析 小鼠
下载PDF
长链非编码RNA alpha-2-巨球蛋白反义RNA 1靶向微小RNA-106b-5p调控氧化型低密度脂蛋白诱导的人脑微血管内皮细胞损伤
5
作者 李薇 王丽 +2 位作者 汪志华 刘庆春 韩荣胜 《解剖学报》 CAS CSCD 北大核心 2023年第3期319-327,共9页
目的探讨长链非编码RNA(lncRNA)alpha-2-巨球蛋白反义RNA 1(A2M-AS1)靶向微小RNA(miR)-106b-5p对氧化型低密度脂蛋白(ox-LDL)诱导的人脑微血管内皮细胞损伤的影响。方法用ox-LDL诱导人脑微血管内皮细胞设为ox-LDL组,正常培养细胞为对照(... 目的探讨长链非编码RNA(lncRNA)alpha-2-巨球蛋白反义RNA 1(A2M-AS1)靶向微小RNA(miR)-106b-5p对氧化型低密度脂蛋白(ox-LDL)诱导的人脑微血管内皮细胞损伤的影响。方法用ox-LDL诱导人脑微血管内皮细胞设为ox-LDL组,正常培养细胞为对照(Ctrl)组;A2M-AS1过表达(pcDNA-A2M-AS1组)、空载体(pcDNA组)、miR-106b-5p抑制剂(anti-miR-106b-5p组)、阴性对照(anti-miR-NC组)、pcDNA-A2M-AS1与对照mimic NC(miR-NC组)、pcDNA-A2M-AS1与miR-106b-5p模拟物(miR-106b-5p mimics组)转染细胞后加ox-LDL处理,n=9;Real-time PCR检测A2M-AS1与miR-106b-5p表达;试剂盒检测丙二醛(MDA)、超氧化物歧化酶(SOD)和过氧化氢酶(CAT)水平;流式细胞术及TUNEL法检测细胞凋亡;双荧光素酶报告基因实验检测A2M-AS1与miR-106b-5p靶向关系;Western blotting检测Bcl-2和Bax蛋白表达量。结果与Ctrl组比较,ox-LDL组A2M-AS1表达水平、SOD和CAT活性、Bcl-2蛋白水平降低,miR-106b-5p表达水平、MDA水平、凋亡率、Bax蛋白水平升高(P<0.05);过表达A2M-AS1或干扰miR-106b-5p降低ox-LDL诱导细胞后MDA水平、凋亡率与Bax蛋白水平,升高SOD、CAT活性和Bcl-2蛋白水平(P<0.05);A2M-AS1靶向miR-106b-5p;上调miR-106b-5p逆转过表达lncRNA A2M-AS1对ox-LDL诱导的人脑微血管内皮细胞损伤的作用。结论A2M-AS1通过靶向miR-106b-5p减轻ox-LDL诱导的人脑微血管内皮细胞损伤。 展开更多
关键词 长链非编码RNA alpha-2-巨球蛋白反义RNA 1 微小RNA-106b-5p 氧化型低密度脂蛋白 氧化应激 实时定量聚合酶链反应 流式细胞术 人脑微血管内皮细胞
下载PDF
Study of the Effect of Zhuang Medicine Aponeurotic System Triple Therapy on Lumbar Disc Herniation and Alpha-1 Acid Glycoprotein Level
6
作者 Yun Zhang Yuying Lan Yingcai Wei 《Journal of Clinical and Nursing Research》 2023年第2期92-99,共8页
Objective:To analyze the application effect of Zhuang medicine aponeurotic system triple therapy in the treatment of lumbar disc herniation and its effect on the level of alpha-1 acid glycoprotein(alpha-1 AGP).Methods... Objective:To analyze the application effect of Zhuang medicine aponeurotic system triple therapy in the treatment of lumbar disc herniation and its effect on the level of alpha-1 acid glycoprotein(alpha-1 AGP).Methods:200 patients with lumbar disc herniation were selected and randomly divided into a treatment group and a control group,100 cases in each group.The control group was given conventional acupuncture,and the treatment group was treated with manipulation+fire needling+cupping.The alpha-1-AGP levels before and after treatment,as well as the lumbar spine function and pain scores before and after treatment,and the adverse reactions occurred during treatment between the two groups were compared.Results:Before treatment,there was no significant difference in alpha-1 AGP levels,lumbar function,and pain scores between the two groups(P>0.05).After treatment,the lumbar function scores of the two groups were significantly increased,with the treatment group having higher scores than the control group(P<0.05);the incidence of adverse reactions in the treatment group was 2.00%,which was much lower than the control group(P>0.05).Conclusion:Appropriate application of Zhuang medicine aponeurotic system triple therapy in the clinical treatment of lumbar disc herniation can promote the improvement of alpha-1 AGP index level,reduce the pain degree of patients,and improve their lumbar spine function.At the same time,Zhuang medicine also has significant advantages in terms of safety,while ensuring the efficacy and safety of the treatment. 展开更多
关键词 Zhuang medicine aponeurotic system triple therapy Lumbar disc herniation Application effect alpha-1 acid glycoprotein
下载PDF
Alpha-黑素细胞刺激素对内毒素血症小鼠肝肺组织表达高迁移率族蛋白1的抑制作用 被引量:3
7
作者 武文 朱玉珍 +1 位作者 韩德平 田野苹 《中国急救医学》 CAS CSCD 北大核心 2008年第5期426-429,共4页
目的研究Alpha-黑素细胞刺激素(α-MSH)对内毒素血症小鼠肝、肺组织中表达高迁移率族蛋白1(HMGB1)的调控作用。方法腹腔内注射(ip)LPS(25g/kg)和D-Gal(100mg/kg)建立内毒素血症小鼠模型,分别在LPS刺激小鼠1、2、3h后腹腔注射α-MSH(2.5m... 目的研究Alpha-黑素细胞刺激素(α-MSH)对内毒素血症小鼠肝、肺组织中表达高迁移率族蛋白1(HMGB1)的调控作用。方法腹腔内注射(ip)LPS(25g/kg)和D-Gal(100mg/kg)建立内毒素血症小鼠模型,分别在LPS刺激小鼠1、2、3h后腹腔注射α-MSH(2.5mg/kg),24h后处死小鼠,取小鼠肺、脑、脾、肝、肾组织,应用RT-PCR和Westernblot的方法,从基因、蛋白两个水平检测α-MSH对HMGB1表达的调节作用。结果HMGB1mRNA及蛋白在内毒素血症小鼠肺、脑、脾、肝、肾中均有表达,但在肝、肺中的表达量高于其他组织;于LPS刺激小鼠3h之内腹腔注射α-MSH,能显著下调HMGB1mRNA及蛋白的表达,并且1h之内给药效果最理想。结论α-MSH能有效抑制内毒素血症小鼠肝、肺组织中HMGB1的表达。 展开更多
关键词 alpha-黑素细胞刺激素 高迁移率族蛋白1 内毒素血症
下载PDF
DETECTION OF ALPHA-1 ANTICHYMOTRYPSIN IN HEPATOCELLULAR CARCINOMA TISSUE
8
作者 荆雪枫 于佩良 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1991年第3期56-59,共4页
One hundred and fifty-three consecutive cases of HCC and 25 controls from autopsy material were studied by immunohistochemical method in this paper. A review of the histopathology and demonstration of AFP, alpha- 1-an... One hundred and fifty-three consecutive cases of HCC and 25 controls from autopsy material were studied by immunohistochemical method in this paper. A review of the histopathology and demonstration of AFP, alpha- 1-antichymotrypsin (AACT), alpha 1-antitrypsin (AAT) and CEA were made.Among the tumor markers. AACT yielded the highest positive rate, 109 cases (71%) out of 153 HCC. CEA was the next, 95 cases (62%) .AFP and AAT gave the same result, 72 cases (47%) . AACT, AAT and CEA were not found in the controls. AFP was present in a few hepatocytes in 1 of 25 controls. The results were in keeping with serum tests so far as the highest positive rate being AACT was concerned. Therefore, combined determination of AACT and AFP would seem a better screening method than by that of AFP alone for survey of HCC. 展开更多
关键词 alpha fetal protein alpha- 1-antichymotrypsin alpha-1-antitrypsin hepatoma.
下载PDF
SlimQuick ^_(TM)-associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity
9
作者 Douglas H Weinstein William S Twaddell +2 位作者 Jean-Pierre Raufman Benjamin Philosophe Ayse L Mindikoglu 《World Journal of Hepatology》 2012年第4期154-157,共4页
Green tea (Camellia sinensis)-associated hepatotoxicity is reported. However, the presence of alpha-1 antitrypsin MZ phenotype as a predisposing factor to green tea-associated drug-induced liver injury (DILI) is unkno... Green tea (Camellia sinensis)-associated hepatotoxicity is reported. However, the presence of alpha-1 antitrypsin MZ phenotype as a predisposing factor to green tea-associated drug-induced liver injury (DILI) is unknown. A previously healthy woman with alpha-1 antitrypsin MZ phenotype who took SlimQuick?, an herbal supplement containing green tea extract, developed severe hepatotoxicity requiring corticosteroid treatment. Green tea-associated hepatotoxicity is reviewed and alpha-1 antitrypsin MZ phenotype as a predisposing factor to green tea-associated DILI is discussed. Liver biopsy demonstrated marked inflammation with necrosis suggestive of toxic injury with diffuse alpha-1 antitrypsin globule deposition on immunostaining. Corticosteroid therapy resulted in rapid clinical improvement. Alpha-1 antitrypsin MZ phenotype may increase vulnerability to herbal hepatotoxicity. 展开更多
关键词 SlimQuick ^_(TM) Green tea HEPATOTOXICITY Drug-induced liver injury alpha-1-antitrypsin MZ phenotype
下载PDF
Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease 被引量:3
10
作者 Clara Antoury Rocio Lopez +2 位作者 Nizar Zein James K Stoller Naim Alkhouri 《World Journal of Hepatology》 CAS 2015年第10期1427-1432,共6页
AIM:To evaluate the association between alpha-1 antitrypsin deficiency(A1ATD) and hepatocellular carcinoma(HCC) in patients with end-stage liver disease(ESLD).METHODS:Patients with cirrhosis and ESLD referred to the C... AIM:To evaluate the association between alpha-1 antitrypsin deficiency(A1ATD) and hepatocellular carcinoma(HCC) in patients with end-stage liver disease(ESLD).METHODS:Patients with cirrhosis and ESLD referred to the Cleveland Clinic Foundation for liver transplantation between 2003 and 2014 were included in the study(N = 675). ESLD was defined as having histological features of cirrhosis and/or radiological evidence of cirrhosis in the context of portal hypertension(ascites,variceal bleeding,thrombocytopenia,or hepatic encephalopathy). A1 ATD was diagnosed using phenotype characterization(MZ or ZZ),liver biopsy detection of PAS-positive diastaseresistant(PAS+) globules,or both. Patients with other causes of liver diseases such as hepatitis C virus(HCV),alcoholic liver disease and non-alcoholic steatohepatitis(NASH) or NASH were also included in the study. HCC was diagnosed by using imaging modalities,biopsy findings,or explanted liver inspection. Follow-up time was defined as the number of years from the diagnosis of cirrhosis to the diagnosis of hepatocellular carcinoma,or from the diagnosis of cirrhosis to the last follow up visit. The rate of HCC was assessed using time-tointerval analysis for interval censored data.RESULTS:This study included 675 patients. 7% of subjects had A1ATD(n = 47). Out of all subjects who did not have A1 ATD,46% had HCV,17% had alcoholic liver disease,19% had NASH and 18% had another primary diagnosis. Of the 47 subjects with A1 ATD,15 had a primary diagnosis of A1ATD(PI*ZZ phenotype and PAS+ globules),8 had a PI*MZ phenotype alone,14 had PAS+ alone,and 10 had both the PI*MZ phenotype and PAS+. Median follow-up time was 3.4(25th,75 th percentiles:1,5.2) years. The overall rate of hepatocellular carcinoma in all subjects was 29%(n = 199). In the A1 ATD group,the incidence rate of HCC was 8.5% compared to 31% in the group of patients with other causes of cirrhosis(P = 0.001). Patients with ESLD due to A1 ATD had the lowest yearly cumulative rate of hepatocellular carcinoma at 0.88% per year compared to 2.7% for those with HCV cirrhosis,1.5% in patients with NASH and 0.9% in alcohol-induced liver disease(P < 0.001).CONCLUSION:Within this group of patients with ESLD,there was no significant association between A1 ATD and increased risk of HCC. 展开更多
关键词 Hepatocellular carcinoma LIVER CIRRHOSIS END-STAGE LIVER disease Hepatitis C virus alpha-1antitrypsin DEFICIENCY
下载PDF
急性呼吸窘迫综合征患者血清α1-抗胰凝乳蛋白酶和α1-抗胰蛋白酶表达水平及临床意义
11
作者 余海波 孟莉 +1 位作者 彭飞 沈杨 《现代检验医学杂志》 CAS 2023年第6期159-165,共7页
目的 探究血清α1-抗胰凝乳蛋白酶(alpha-1-antichymotrypsin,AACT)和α1-抗胰蛋白酶(alpha-1-antitrypsin,AAT)在急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS)患者中的表达情况及二者的临床意义。方法选取2019年1月~... 目的 探究血清α1-抗胰凝乳蛋白酶(alpha-1-antichymotrypsin,AACT)和α1-抗胰蛋白酶(alpha-1-antitrypsin,AAT)在急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS)患者中的表达情况及二者的临床意义。方法选取2019年1月~2022年12月四川绵阳四〇四医院收治的84例ARDS患者作为疾病组,另选取同时期在四川绵阳四〇四医院进行体检的84例健康人作为对照组。采用酶联免疫吸附测定法(enzyme linked immunosorbent assay,ELISA)检查血清AACT和AAT表达水平。采用Kaplan-Meier法分析ARDS患者血清AACT和AAT表达与预后的关系。采用COX回归分析ARDS患者预后影响因素。采用受试者工作特征(receiver operating characteristic,ROC)曲线分析血清AACT和AAT表达对ARDS患者预后的预测价值。结果 疾病组血清AACT(14.02±2.87ng/ml),AAT(4.76±1.19g/L)表达水平均高于对照组(9.56±2.11ng/ml,2.92±0.24g/L),差异具有统计学意义(t=11.475,13.892,均P <0.05)。ARDS患者中AACT与AAT高表达组生存率[40.00%(18/45),39.02%(16/41)]分别低于AACT与AAT低表达组生存率[84.62%(33/39),81.40%(35/43)],差异具有统计学意义(χ^(2)=17.436,15.797,均P <0.001)。并发下呼吸道感染(HR=3.188,P=0.013)、使用血管活性物质(HR=2.656,P=0.045)、免疫抑制药物(HR=6.118,P=0.001)、发病至治疗时长(HR=5.202,P=0.005)、急性生理与慢性健康评分Ⅱ(acute physiology and chronic health score Ⅱ,APACHE Ⅱ)(HR=5.368,P=0.003)、血清AACT(HR=3.976,P=0.009)和AAT(HR=4.773,P=0.008)水平均为ARDS患者30天死亡的危险因素,氧合指数(oxygenation index,OI)(HR=0.402,P=0.007)、有创机械通气时间(HR=0.461,P=0.013)为保护因素(P <0.05)。血清AACT与AAT联合预测ARDS患者预后不良的ROC曲线下面积(area under the curve,AUC)(95%CI)为0.920(0.841~0.968),高于血清AACT与AAT单独预测[0.778(0.675~0.862),0.793(0.691~0.874)],差异有统计学意义(Z=2.456,2.466,均P <0.05)。结论 ARDS患者血清AACT与AAT水平均升高,二者均与患者30天生存预后密切相关,二者均对ARDS患者预后具有一定预测价值,且二者联合的预测价值更高。 展开更多
关键词 α1-抗胰凝乳蛋白酶 Α1-抗胰蛋白酶 急性呼吸窘迫综合征
下载PDF
On the Activities of Pancreatic Proteases and Alpha-1 Proteinase Inhibitor in Meat-Type Chicken
12
作者 Vladimir G. Vertiprakhov Alena A. Grozina +3 位作者 Ivan A. Egorov Tatiana N. Lenkova Vardges A. Manukyan Tatiana A. Egorova 《Open Journal of Animal Sciences》 2017年第3期289-296,共8页
The study was aimed at the evaluation of the effects of breed, age, different digestion stimulators, and dietary crude protein (CP) level on the activities of proteolytic enzymes in pancreatic tissue and duodenal chym... The study was aimed at the evaluation of the effects of breed, age, different digestion stimulators, and dietary crude protein (CP) level on the activities of proteolytic enzymes in pancreatic tissue and duodenal chymus (in vivo), serum trypsin and α1-proteinase inhibitor (A1PI) concentrations in meat-type chicks. The study of age dynamics of trypsin and A1PI concentrations was performed on the chicks of hybrid cross “Smena-8”and two parental lines (Plymouth Rock and Cornish) fed standard commercial corn-wheat-SBM diets. Twenty birds per breed were euthanized at 1, 7, 14, 21, 28 and 35 days of age to obtain blood samples and pancreatic homogenate. Experiments on the effects of different digestion promotors (probiotic, acidifier, phytobiotic, enzymatic preparation) and different CP levels (finisher diet, CP 20%, vs. ground corn, CP 8.5%) were performed on 12 hybrid chicks with fistulated duodenum from 14 to 50 days of age. The following conclusions were made: 1) At 1 day of age high proteolytic activity in pancreatic tissue and maximal serum concentrations of trypsin and A1PI were found in both hybrid and parental lines. Since 7 to 35 days of age A1PI concentration was nearly constant, serum trypsin concentration decreased while proteolytic activity in pancreatic tissue exhibited undulate increase;2) Proteolytic activity in pancreatic tissue was higher in hybrids compared to the parental lines from 7 to 35 days of age (p 0.05);3) Supplementation of diet with exogenous enzymes stimulated the digestion due to the increase in protease activity in duodenal chymus by 9.1% compared to unsupplemented control (p 0.05);4) Proteolytic activity in duodenal chymus significantly responded to the substitution of ground corn for the complete diet by 2-fold decrease while serum trypsin concentration responded by 2.5-fold increase (p 0.001). This fact can indicate that physiological functions of digestive proteases are not confined to the digestive processes. 展开更多
关键词 CHICKS Pancreas TRYPSIN alpha-1 PROTEINASE Inhibitor (Antitrypsin) Serum DUODENAL Fluid
下载PDF
α1-AT/DNaseⅠ、HBD-1、SF在重症儿童社区获得性肺炎患儿中的表达及其临床意义
13
作者 周宇阳 杨军杰 《医学临床研究》 CAS 2023年第8期1211-1213,1217,共4页
【目的】探讨α1-抗胰蛋白酶(α1-AT)/DNA酶Ⅰ(DNaseⅠ)、β-防御素1(HBD-1)、铁蛋白(SF)在重症社区获得性肺炎(SCAP)患儿中的表达及其临床意义。【方法】选取2020年1月至2021年5月开封市儿童医院收治的98例SCAP患儿(观察组),根据肺炎... 【目的】探讨α1-抗胰蛋白酶(α1-AT)/DNA酶Ⅰ(DNaseⅠ)、β-防御素1(HBD-1)、铁蛋白(SF)在重症社区获得性肺炎(SCAP)患儿中的表达及其临床意义。【方法】选取2020年1月至2021年5月开封市儿童医院收治的98例SCAP患儿(观察组),根据肺炎严重指数(PSI)分为低危组(n=15)、中危组(n=52)、高危组(n=31),根据检测结果分为细菌性肺炎组(n=50)、支原体肺炎组(n=22)、病毒性肺炎组(n=26),同时选取同期于本院体检的62例健康儿童作为对照组。比较不同组间血清α1-AT/DNaseⅠ、HBD-1、SF水平,采用Spearman法分析α1-AT/DNaseⅠ、HBD-1、SF与疾病严重程度的相关性,采用受试者工作特征(ROC)曲线评估上述指标对SCAP的诊断价值。【结果】观察组血清α1-AT/DNaseⅠ、HBD-1、SF水平高于对照组,差异有统计学意义(P<0.05)。单因素方差分析显示,不同疾病严重程度的SCAP患儿血清α1-AT/DNaseⅠ、HBD-1、SF水平比较,差异有统计学意义(P<0.05)。中危组、高危组血清α1-AT/DNaseⅠ、HBD-1、SF水平高于低危组,且高危组高于中危组,差异有统计学意义(P<0.05)。支原体肺炎组、病毒性肺炎组α1-AT/DNaseⅠ、HBD-1、SF水平高于细菌性肺炎组(P<0.05),支原体肺炎组、病毒性肺炎组比较,差异无统计学意义(P>0.05)。Spearman相关性分析显示,α1-AT/DNaseⅠ、HBD-1、SF均与疾病严重程度呈正相关(r_(s)=0.632、0.524、0.531,均P<0.01)。ROC曲线分析显示,α1-AT/DNaseⅠ、HBD-1、SF联合检测的曲线下面积、敏感度、特异度明显高于单项检测(P<0.05)。【结论】SCAP患儿血清中α1-AT/DNaseⅠ、HBD-1、SF水平异常升高,且与病情程度有关,联合检测可提高SCAP诊断价值。 展开更多
关键词 肺炎 社区获得性感染 Α1抗胰蛋白酶 脱氧核糖核酸酶Ⅰ Β防御素 铁蛋白质类
下载PDF
血清A1AT水平与2型糖尿病合并非酒精性脂肪肝及肝脏纤维化的关联性分析
14
作者 泽娜 米玛次仁 扎西卓玛 《中国临床新医学》 2023年第8期816-820,共5页
目的分析血清α1抗胰蛋白酶(A1AT)水平与2型糖尿病(T2DM)合并非酒精性脂肪肝(NAFLD)及肝脏纤维化的关联性。方法招募2019年3月至2020年3月西藏自治区第二人民医院收治的117例T2DM合并NAFLD患者为T2DM+NAFLD组,于同期纳入性别、年龄与NAF... 目的分析血清α1抗胰蛋白酶(A1AT)水平与2型糖尿病(T2DM)合并非酒精性脂肪肝(NAFLD)及肝脏纤维化的关联性。方法招募2019年3月至2020年3月西藏自治区第二人民医院收治的117例T2DM合并NAFLD患者为T2DM+NAFLD组,于同期纳入性别、年龄与NAFLD+T2DM组匹配的单纯T2DM患者(单纯T2DM组)和健康体检者(对照组)各80例。采用免疫比浊法检测血清A1AT水平,采用非酒精性脂肪肝纤维化评分(NAFLDFS)评估患者肝脏纤维化情况。采用多因素logistic回归分析T2DM合并NAFLD的影响因素,采用受试者工作特征(ROC)曲线分析血清A1AT水平对T2DM合并NAFLD的诊断价值,采用Spearman秩相关分析血清A1AT水平与NAFLDFS的相关性。结果多因素logistic回归分析结果显示,较高水平的空腹血糖(FPG)、空腹胰岛素(FINS)、HOMA稳态模型计算胰岛素抵抗指数(HOMA-IR)、甘油三酯(TG)、肝脏脂肪含量(LFC)和A1AT是T2DM患者发生NAFLD的独立危险因素(P<0.05)。ROC曲线分析结果显示,血清A1AT水平具有诊断T2DM患者发生NAFLD的应用价值[AUC(95%CI)=0.793(0.758~0.829),P<0.001],其最佳截断值为2.91 g/L,对应的灵敏度和特异度分别为0.81、0.69。Spearman秩相关分析结果显示,T2DM合并NAFLD患者血清A1AT水平与NAFLDFS呈正相关性(r s=0.635,P<0.001)。结论血清A1AT在T2DM合并NAFLD患者中表达上升,可作为辅助诊断T2DM患者合并NAFLD以及评估肝纤维化程度的生化标志物。 展开更多
关键词 Α1抗胰蛋白酶 2型糖尿病 非酒精性脂肪肝 肝纤维化
下载PDF
Alpha-1 Antitrypsin Deficiency Family Study
15
作者 Osorio, Raquel Femandes, Helena +2 位作者 Cafofo Tomasia Clemente, Helena Fialho, Licinio 《Journal of Life Sciences》 2016年第7期321-323,共3页
关键词 Α1-抗胰蛋白酶 缺乏症 慢性阻塞性肺疾病 慢性阻塞性肺病 遗传性疾病 家系 世界卫生组织 COPD
下载PDF
A novel alpha1-antitrypsin null variant (PiQ0Milano)nt (PiQ0_(Milano))
16
作者 Raffaela Rametta Gabriella Nebbia +3 位作者 Paola Dongiovanni Marcello Farallo Silvia Fargion Luca Valenti 《World Journal of Hepatology》 CAS 2013年第8期458-461,共4页
Alpha1-antitrypsin deficiency is an autosomal recessive disease characterized by reduced serum levels of alpha1-antitrypsin(AAT)due to mutations in the SERPINA1 gene causing early onset pulmonary emphysema and,occasio... Alpha1-antitrypsin deficiency is an autosomal recessive disease characterized by reduced serum levels of alpha1-antitrypsin(AAT)due to mutations in the SERPINA1 gene causing early onset pulmonary emphysema and,occasionally,chronic liver disease.We report an incidental finding of a novel null AAT allele,Q0Milano,consisting of a 17 nucleotides deletion in exon 3 of SERPINA1 gene,in an Italian child with persistently increased liver enzymes,a mild decrease in circulating AAT levels and without any pulmonary disease.Q0Milano variant results in an unfunctional protein lacking of AAT active site,as the resultant protein is truncated near PiS locus involved in AAT protein stability. 展开更多
关键词 Alpha1-antitrypsin DEFICIENCY RARE VARIANT Alpha1-antitrypsin NULL mutation Liver disease
下载PDF
Managing panniculitis in alpha-1 antitrypsin deficiency: Systematic review of evidence behind treatment
17
作者 Donah K Sabbagh Behrad Barmayehvar +2 位作者 Thanh Nguyen Ross G Edgar Alice M Turner 《World Journal of Dermatology》 2018年第1期1-8,共8页
AIM To systematically review literature for management of alpha-1 antitrypsin deficiency(AATD) panniculitis. METHODS Multiple databases were searched using combinations of pertinent terms. Articles were selected descr... AIM To systematically review literature for management of alpha-1 antitrypsin deficiency(AATD) panniculitis. METHODS Multiple databases were searched using combinations of pertinent terms. Articles were selected describing panniculitis treatment in patients with AAT < 11 μmol and/or PiZZ genotype, with no language limitation. All relevant articles were accessed in full text. Independent review of abstracts and full manuscripts was conducted by 2 reviewers, and quality assessment by one reviewer(checked by a second). Data extraction was conducted byone reviewer(checked by a second). Narrative synthesis only was conducted, as data were unsuitable for metaanalysis.RESULTS Thirty-two case reports and 4 case series were found. Augmentation therapy(infusions of plasma-derived AAT) was the most successful, with complete resolution of symptoms in all patients. Dapsone is a less expensive option, and it achieved clinical resolution in 62% of patients, but it is very poorly tolerated. Among other single-agent antibiotics, doxycycline was the most successful with complete clinical resolution seen in 33% of patients. Immunosuppressants were largely unsuccessful; 80% of patients exhibited no response. Liver transplantation and therapeutic plasma exchange displayed complete resolution in 66% of patients. Other strategies, such as non-steroidal anti-inflammatory drugs or antibiotics other than dapsone did not show sufficient response rates to recommend their use. Authors note the risk of bias imposed by the type of evidence(case reports, case series) available in this field.CONCLUSION Dapsone is the recommended first line therapy for AATD panniculitis, followed by augmentation therapy. Plasma exchange may be an alternative in the setting of rapidly progressive disease. 展开更多
关键词 alpha-1 ANTITRYPSIN DEFICIENCY Dermatological TREATMENT PANNICULITIS DAPSONE Augmentation therapy
下载PDF
IMMUNOHISTOCHEMICAL STUDY OF ALPHA-1-ANTICHYMOTRYPSIN IN GLIOMA
18
作者 李青 王文亮 刘彦仿 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1989年第3期42-45,共4页
GFAP is a specific antigen of glial element, but Alpha-1-antichymotrypsin has not been reported in the literature. Alpha-1-antichymotrypsin was guided by GFAP using PAP method to the astrocytes of 137 gliomas. 120 (87... GFAP is a specific antigen of glial element, but Alpha-1-antichymotrypsin has not been reported in the literature. Alpha-1-antichymotrypsin was guided by GFAP using PAP method to the astrocytes of 137 gliomas. 120 (87%) gliomas were positive for Alpha-1-antichymotrypsin. Of these 120 gliomas, 86 (72%) gave diffuse distribution, 17 (14%) gave focal distribution, and 17 (14%) gave scattered distributions. Alpha-1-antichymotrypsin in glioma tissue may be an important tumor marker for diagnosis. 展开更多
关键词 GFAP IMMUNOHISTOCHEMICAL STUDY OF alpha-1-ANTICHYMOTRYPSIN IN GLIOMA
下载PDF
α1-antitrypsin combined with bone marrow mesenchymal stem cells regulates retinopathy in diabetic rats via p38 MAPK/NF-κB signaling pathway
19
作者 Hong Chen Chu-Hua Li +3 位作者 Wen-Jun Wang Rong Zeng Huan-Huan Yan Hong Zhang 《Journal of Hainan Medical University》 2021年第1期10-15,共6页
Objective:To investigate the effect ofα1-antitrypsin combined with bone marrow mesenchymal stem cells on retinopathy in diabetic rats and its mechanism.Methods:A model of diabetic retinopathy was established by intra... Objective:To investigate the effect ofα1-antitrypsin combined with bone marrow mesenchymal stem cells on retinopathy in diabetic rats and its mechanism.Methods:A model of diabetic retinopathy was established by intraperitoneal injection of streptozotocin.The 30 Wistar rats successfully modeled were randomly divided into a model group,a bone marrow mesenchymal stem cell group and a combined group(α1-antitrypsin combined with bone marrow Mesenchymal stem cells),the blood glucose and serum insulin levels of diabetic rats were measured 4 weeks after treatment.Enzyme-linked immunosorbent assay(ELISA)for measuring serum inflammatory factors IL-1β,IL-6 and TNF-α in rats.Observing the pathological morphology of rat retina under hematoxylin-eosin staining(HE).TUNEL staining to observe the apoptosis of rat retinal nerve cells.Immunohistochemical method to detect the expression level of CD45 in retinal tissue.Real-time fluorescence quantitative PCR was used to detect the expression of retinal vascular endothelial growth factor(VEGF),hypoxiainducible factor-1α(HIF-1α),and angiotensinⅡ(ANGⅡ)mRNA.Western blot was used to detect the expression of p38 MAPK/NF-κB signaling pathway-related proteins in the retinal tissue of each group of rats.Results:Compared with the control group,the rats in the model group had increased blood glucose,decreased insulin levels,increased serum IL-1β,IL-6,and TNF-α levels,and had obvious lesions in the retina.CD45 showed high expression in retinal tissue,VEGF,HIF-1α,ANGⅡ mRNA expression increased,p-p38,p-p65,p-IκBα protein expression increased(P<0.05).Compared with the model group,the bone marrow mesenchymal stem cell group and the combined group have decreased blood glucose,increased insulin levels,and decreased serum IL-1β,IL-6 and TNF-α levels.Retinopathy is improved,apoptosis of retinal nerve cells is reduced,CD45 expression in retinal tissue is reduced,VEGF,HIF-1α,ANGⅡ mRNA expression is decreased,and p-p38,p-p65,p-IκBα protein expression is decreased.Compared with the bone marrow mesenchymal stem cell group,the effect of the combined group was more obvious(P<0.05).Conclusion:α1-antitrypsin combined with bone marrow mesenchymal stem cell transplantation can improve the degree of retinopathy in diabetic rats.The mechanism may be related to the inhibition of p38 MAPK/NF-κB signaling pathway. 展开更多
关键词 Α1-antitrypsin Bone marrow mesenchymal stem cells DIABETES RETINOPATHY Vascular endothelial growth factor p38 MAPK/NF-κB pathway
下载PDF
氧化型α1-抗胰蛋白酶的表达变化与组织学绒毛膜羊膜炎的关系 被引量:2
20
作者 陶贝贝 程国梅 +2 位作者 张林东 赵岚岚 崔世红 《实用医学杂志》 CAS 北大核心 2013年第22期3658-3660,共3页
目的:探讨胎膜早破孕妇外周血、脐血和胎膜组织中氧化型α1-抗胰蛋白酶(ox-AAT)的表达变化与组织学绒毛膜羊膜炎(histological chorioamnionitis,HCA)的关系。方法:选择胎膜早破孕妇90例,根据是否合并HCA分为实验组和对照组。采用ELISA... 目的:探讨胎膜早破孕妇外周血、脐血和胎膜组织中氧化型α1-抗胰蛋白酶(ox-AAT)的表达变化与组织学绒毛膜羊膜炎(histological chorioamnionitis,HCA)的关系。方法:选择胎膜早破孕妇90例,根据是否合并HCA分为实验组和对照组。采用ELISA法检测孕妇外周血及新生儿脐血中ox-AAT的水平;逆转录-PCR技术检测胎膜组织中ox-AAT mRNA的表达水平。结果:病理结果示:实验组38例,对照组52例。实验组血清、脐血中ox-AAT水平(2.415±0.105)ng/L、(3.023±0.186)ng/L高于对照组(1.526±0.10)ng/L、(2.357±0.104)ng/L(P<0.05);实验组胎膜组织中ox-AAT mRNA(0.883±0.027)水平高于对照组(0.449±0.011)(P<0.05)。实验组血清、脐血及胎膜组织中ox-AAT的水平均成正相关(P<0.05)。实验组新生儿肺炎发病率高于对照组(P<0.05)。结论:胎膜早破孕妇外周血、脐血和胎膜组织中ox-AAT水平升高与合并HCA及新生儿肺炎相关。 展开更多
关键词 胎膜早破 组织学绒毛膜羊膜炎 氧化型α1-抗胰蛋白酶 新生儿
下载PDF
上一页 1 2 5 下一页 到第
使用帮助 返回顶部